SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-19-172660
Filing Date
2019-06-14
Accepted
2019-06-13 18:42:07
Documents
66
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q d707197d10q.htm 10-Q 870005
2 EX-31.1 d707197dex311.htm EX-31.1 6892
3 EX-31.2 d707197dex312.htm EX-31.2 6956
4 EX-32.1 d707197dex321.htm EX-32.1 3790
5 EX-32.2 d707197dex322.htm EX-32.2 3696
  Complete submission text file 0001193125-19-172660.txt   5117099

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT trvi-20190331.xml EX-101.INS 1159043
7 XBRL TAXONOMY EXTENSION SCHEMA trvi-20190331.xsd EX-101.SCH 50688
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE trvi-20190331_cal.xml EX-101.CAL 35285
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE trvi-20190331_def.xml EX-101.DEF 223467
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE trvi-20190331_lab.xml EX-101.LAB 342260
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE trvi-20190331_pre.xml EX-101.PRE 309064
Mailing Address 195 CHURCH STREET 14TH FLOOR NEW HAVEN CT 06510
Business Address 195 CHURCH STREET 14TH FLOOR NEW HAVEN CT 06510 203-304-2499
Trevi Therapeutics, Inc. (Filer) CIK: 0001563880 (see all company filings)

IRS No.: 450834299 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38886 | Film No.: 19897265
SIC: 2834 Pharmaceutical Preparations